{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:33:27Z","timestamp":1792794807044,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"crossref","award":["Grant Number JP19K17758"],"award-info":[{"award-number":["Grant Number JP19K17758"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012832","name":"Okinaka Memorial Institute for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012832","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cyst infection is a frequent and serious complication of autosomal dominant polycystic kidney disease (ADPKD) that is often difficult to treat and can be fatal. However, much is still unknown about cyst infection. Positron emission tomography (PET) is generally recommended for detecting infected cysts, but it has the disadvantages of limited availability, high cost, and radiation exposure. We have devised magnetic resonance imaging (MRI) diagnostic criteria for cyst infection. Lipid-soluble antibiotics such as fluoroquinolones show good penetration into cysts and are recommended for cyst infection. However, we reported that fluoroquinolone-resistant microorganisms showed a high prevalence in cyst infection. We should, therefore, reconsider the empirical use of fluoroquinolones for ADPKD patients with cyst infection. We have suggested a new antibiotic strategy according to the severity of cyst infection. It may be important to consider the drug half-life in serum in addition to the drug susceptibility when selecting antibiotics Cyst drainage is necessary for some patients with refractory cyst infection; however, cyst drainage can be associated with severe adverse events. We suggest adaptation criteria for cyst drainage in patients with cyst infection in ADPKD. Most causative bacteria of cyst infection are enterobacteria, and hematogenous spread via bacterial translocation in the intestine is considered the main cause of cyst infection. Therefore, intestinal flora may be important for cyst infection. The role of the intestinal flora in cyst infection in ADPKD is unknown and should be explored in future research.<\/jats:p>","DOI":"10.1007\/s10157-020-01928-2","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T08:09:31Z","timestamp":1595405371000},"page":"748-761","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cyst infection in autosomal dominant polycystic kidney disease: our experience at Toranomon Hospital and future issues"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0825-2512","authenticated-orcid":false,"given":"Tatsuya","family":"Suwabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"key":"1928_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2215\/CJN.05900519","volume":"15","author":"T Suwabe","year":"2020","unstructured":"Suwabe T, Shukoor S, Chamberlain AM, Killian JM, King BF, Edwards M, Senum SR, Madsen CD, Chebib FT, Hogan MC, Cornec-Le Gall E, Harris PC, Torres VE. Epidemiology of autosomal dominant polycystic kidney disease in olmsted county. Clin J Am Soc Nephrol. 2020;15:69\u201379.","journal-title":"Clin J Am Soc Nephrol."},{"key":"1928_CR2","volume-title":"Polycystic kidney disase autosomal-dominant and recessive forms","author":"VE Torres","year":"2001","unstructured":"Torres VE. Polycystic kidney disase autosomal-dominant and recessive forms. Philadelphia: Lippincott Williams & Wilkins; 2001."},{"key":"1928_CR3","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0002-9343(87)90005-2","volume":"82","author":"SJ Schwab","year":"1987","unstructured":"Schwab SJ, Bander SJ, Klahr S. Renal infection in autosomal dominant polycystic kidney disease. Am J Med. 1987;82:714\u20138.","journal-title":"Am J Med."},{"key":"1928_CR4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0272-6386(84)80002-5","volume":"3","author":"KD Gardner Jr","year":"1984","unstructured":"Gardner KD Jr, Evan AP. Cystic kidneys: an enigma evolves. Am J Kidney Dis. 1984;3:403\u201313.","journal-title":"Am J Kidney Dis."},{"key":"1928_CR5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2215\/CJN.01870309","volume":"4","author":"M Sallee","year":"2009","unstructured":"Sallee M, Rafat C, Zahar JR, Paulmier B, Grunfeld JP, Knebelmann B, Fakhouri F. Cyst infections in patients with autosomal dominant polycystic kidney disease. CJASN. 2009;4:1183\u20139.","journal-title":"CJASN."},{"key":"1928_CR6","doi-asserted-by":"crossref","first-page":"c157","DOI":"10.1159\/000214211","volume":"112","author":"T Suwabe","year":"2009","unstructured":"Suwabe T, Ubara Y, Higa Y, Nakanishi S, Sogawa Y, Nomura K, Nishimura H, Hoshino J, Sawa N, Katori H, Takemoto F, Nakamura M, Tomikawa S, Hara S, Takaichi K. Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney disease. Nephron Clin Pract. 2009;112:c157\u201363.","journal-title":"Nephron Clin Pract."},{"key":"1928_CR7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s10157-013-0927-0","volume":"19","author":"Y Hattori","year":"2015","unstructured":"Hattori Y, Hoshino J, Suwabe T, Sumida K, Mise K, Hayami N, Sawa N, Takaichi K, Ubara Y. Umbilical hernia in autosomal dominant polycystic kidney disease. Clin Experim Nephrol. 2015;19:154\u20136.","journal-title":"Clin Experim Nephrol."},{"key":"1928_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","volume":"88","author":"AB Chapman","year":"2015","unstructured":"Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC, Conference P. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2015;88:17\u201327.","journal-title":"Kidney Int."},{"key":"1928_CR9","first-page":"144","volume":"32","author":"MA Lantinga","year":"2017","unstructured":"Lantinga MA, Casteleijn NF, Geudens A, de Sevaux RG, van Assen S, Leliveld AM, Gansevoort RT, Drenth JP, Consortium D. Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review. Nephrol Dial Transplant. 2017;32:144\u201350.","journal-title":"Nephrol Dial Transplant."},{"key":"1928_CR10","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1681\/ASN.2015010067","volume":"27","author":"T Suwabe","year":"2016","unstructured":"Suwabe T, Ubara Y, Mise K, Ueno T, Sumida K, Yamanouchi M, Hayami N, Hoshino J, Kawada M, Imafuku A, Hiramatsu R, Hasegawa E, Sawa N, Takaichi K. Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization. JASN. 2016;27:2177\u201387.","journal-title":"JASN."},{"key":"1928_CR11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1053\/j.ajkd.2014.01.422","volume":"63","author":"J Hoshino","year":"2014","unstructured":"Hoshino J, Ubara Y, Suwabe T, Sumida K, Hayami N, Mise K, Hiramatsu R, Hasegawa E, Yamanouchi M, Sawa N, Takei R, Takaichi K. Intravascular embolization therapy in patients with enlarged polycystic liver. Am J Kidney Dis. 2014;63:937\u201344.","journal-title":"Am J Kidney Dis"},{"key":"1928_CR12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s002709900419","volume":"22","author":"ST Hahn","year":"1999","unstructured":"Hahn ST, Park SH, Lee JM, Kim CY, Chang YS. Renal artery embolization controls intractable pain in a patient with polycystic kidney disease. Cardiovasc Intervent Radiol. 1999;22:422\u20134.","journal-title":"Cardiovasc Intervent Radiol."},{"key":"1928_CR13","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jvir.2011.07.003","volume":"22","author":"H Morishita","year":"2011","unstructured":"Morishita H, Yamagami T, Takeuchi Y, Matsumoto T, Asai S, Nakanouchi T, Sato O, Nishimura T. Use of N-butyl-2-cyanoacrylate for transcatheter arterial embolization of renal arteries in patients with polycystic kidney disease. JVIR. 2011;22:1631\u20133.","journal-title":"JVIR."},{"key":"1928_CR14","first-page":"347","volume":"65","author":"T Mukai","year":"2011","unstructured":"Mukai T, Mimura H, Gobara H, Shimizu M, Niiya H, Kanazawa S. A case of renal transcatheter arterial embolization with ethanol in autosomal dominant polycystic kidney disease for volume reduction. Acta Medica Okayama. 2011;65:347\u201351.","journal-title":"Acta Medica Okayama."},{"key":"1928_CR15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3348\/kjr.2010.11.5.574","volume":"11","author":"H Rim","year":"2010","unstructured":"Rim H, Jung GS, Jung YS. Transcatheter arterial embolization using ethanol in a dialysis patient for contracting enlarged polycystic kidneys. Korean J Radiol. 2010;11:574\u20138.","journal-title":"Korean J Radiol."},{"key":"1928_CR16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jvir.2007.10.007","volume":"19","author":"Y Sakuhara","year":"2008","unstructured":"Sakuhara Y, Kato F, Abo D, Hasegawa Y, Shimizu T, Terae S, Shirato H. Transcatheter arterial embolization with absolute ethanol injection for enlarged polycystic kidneys after failed metallic coil embolization. JVIR. 2008;19:267\u201371.","journal-title":"JVIR."},{"key":"1928_CR17","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1007\/s00330-015-3730-3","volume":"25","author":"F Petitpierre","year":"2015","unstructured":"Petitpierre F, Cornelis F, Couzi L, Lasserre AS, Tricaud E, Le Bras Y, Merville P, Combe C, Ferriere JM, Grenier N. Embolization of renal arteries before transplantation in patients with polycystic kidney disease: a single institution long-term experience. Eur Radiol. 2015;25:3263\u201371.","journal-title":"Eur Radiol."},{"key":"1928_CR18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2967\/jnmt.107.049627","volume":"36","author":"E Laffon","year":"2008","unstructured":"Laffon E, Cazeau AL, Monet A, de Clermont H, Fernandez P, Marthan R, Ducassou D. The effect of renal failure on 18F-FDG uptake: a theoretic assessment. J Nucl Med Technol. 2008;36:200\u20132.","journal-title":"J Nucl Med Technol."},{"key":"1928_CR19","unstructured":". In: OECD.Stat. Organisation for economic co-operation and development. https:\/\/stats.oecd.org\/."},{"key":"1928_CR20","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s10157-012-0650-2","volume":"16","author":"T Suwabe","year":"2012","unstructured":"Suwabe T, Ubara Y, Sumida K, Hayami N, Hiramatsu R, Yamanouchi M, Hasegawa E, Hoshino J, Sawa N, Saitoh S, Okuda I, Takaichi K. Clinical features of cyst infection and hemorrhage in ADPKD: new diagnostic criteria. Clin Experim Nephrol. 2012;16:892\u2013902.","journal-title":"Clin Experim Nephrol."},{"key":"1928_CR21","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s10096-015-2361-6","volume":"34","author":"T Suwabe","year":"2015","unstructured":"Suwabe T, Araoka H, Ubara Y, Kikuchi K, Hazue R, Mise K, Hamanoue S, Ueno T, Sumida K, Hayami N, Hoshino J, Imafuku A, Kawada M, Hiramatsu R, Hasegawa E, Sawa N, Takaichi K. Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics. Eur J Clin Microbiol Infect Dis. 2015;34:1369\u201379.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"1928_CR22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12882-016-0381-9","volume":"17","author":"T Suwabe","year":"2016","unstructured":"Suwabe T, Ubara Y, Ueno T, Hayami N, Hoshino J, Imafuku A, Kawada M, Hiramatsu R, Hasegawa E, Sawa N, Saitoh S, Okuda I, Takaichi K. Intracystic magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease: features of severe cyst infection in a case-control study. BMC Nephrol. 2016;17:170.","journal-title":"BMC Nephrol."},{"key":"1928_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000493806","volume":"141","author":"T Suwabe","year":"2019","unstructured":"Suwabe T, Ubara Y, Hayami N, Yamanouchi M, Hiramatsu R, Sumida K, Sawa N, Sekine A, Kawada M, Hasegawa E, Hoshino J, Takaichi K. Factors influencing cyst infection in autosomal dominant polycystic kidney disease. Nephron. 2019;141:75\u201386.","journal-title":"Nephron."},{"key":"1928_CR24","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","volume":"3","author":"S Kato","year":"2008","unstructured":"Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B. Aspects of immune dysfunction in end-stage renal disease. CJASN. 2008;3:1526\u201333.","journal-title":"CJASN."},{"key":"1928_CR25","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1093\/ndt\/gfs352","volume":"27","author":"F Jouret","year":"2012","unstructured":"Jouret F, Lhommel R, Devuyst O, Annet L, Pirson Y, Hassoun Z, Kanaan N. Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities. Nephrol Dial Transplant. 2012;27:3746\u201351.","journal-title":"Nephrol Dial Transplant."},{"key":"1928_CR26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10157-010-0364-2","volume":"15","author":"Y Tsuchiya","year":"2011","unstructured":"Tsuchiya Y, Ubara Y, Suwabe T, Hoshino J, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Marui Y, Sawa N, Takemoto F, Takaichi K. The renal cyst infection caused by Salmonella enteritidis in a patient with autosomal dominant polycystic kidney disease: how did this pathogen come into the renal cysts? Clin Experimen Nephrol. 2011;15:151\u20133.","journal-title":"Clin Experimen Nephrol."},{"key":"1928_CR27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0272-6386(85)80102-5","volume":"6","author":"WM Bennett","year":"1985","unstructured":"Bennett WM, Elzinga L, Pulliam JP, Rashad AL, Barry JM. Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis. 1985;6:400\u20134.","journal-title":"Am J Kidney Dis."},{"key":"1928_CR28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/ki.1981.170","volume":"20","author":"RS Muther","year":"1981","unstructured":"Muther RS, Bennett WM. Cyst fluid antibiotic concentrations in polycystic kidney disease: differences between proximal and distal cysts. Kidney Int. 1981;20:519\u201322.","journal-title":"Kidney Int."},{"key":"1928_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0272-6386(83)80012-2","volume":"3","author":"S Schwab","year":"1983","unstructured":"Schwab S, Hinthorn D, Diederich D, Cuppage F, Grantham J. PH-dependent accumulation of clindamycin in a polycystic kidney. Am J Kidney Dis. 1983;3:63\u20136.","journal-title":"Am J Kidney Dis."},{"key":"1928_CR30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1128\/AAC.32.6.844","volume":"32","author":"LW Elzinga","year":"1988","unstructured":"Elzinga LW, Golper TA, Rashad AL, Carr ME, Bennett WM. Ciprofloxacin activity in cyst fluid from polycystic kidneys. Antimicrob Agent Chemotherapy. 1988;32:844\u20137.","journal-title":"Antimicrob Agent Chemotherapy."},{"key":"1928_CR31","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1053\/j.ajkd.2005.09.021","volume":"47","author":"L Hiyama","year":"2006","unstructured":"Hiyama L, Tang A, Miller LG. Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease. Am J Kidney DIS. 2006;47:e9\u201313.","journal-title":"Am J Kidney DIS."},{"key":"1928_CR32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/106002809302700109","volume":"27","author":"SJ Rossi","year":"1993","unstructured":"Rossi SJ, Healy DP, Savani DV, Deepe G. High-dose ciprofloxacin in the treatment of a renal cyst infection. Annal Pharmacotherapy. 1993;27:38\u20139.","journal-title":"Annal Pharmacotherapy."},{"key":"1928_CR33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0272-6386(86)80094-4","volume":"7","author":"SJ Schwab","year":"1986","unstructured":"Schwab SJ, Weaver ME. Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease. Am J Kidney Dis. 1986;7:434\u20138.","journal-title":"Am J Kidney Dis."},{"key":"1928_CR34","unstructured":"Truven Health Analytics I. Dosing information: dosage in renal failure. DRUGDEX\u00ae2014."},{"key":"1928_CR35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12882-018-1067-2","volume":"19","author":"S Hamanoue","year":"2018","unstructured":"Hamanoue S, Suwabe T, Ubara Y, Kikuchi K, Hazue R, Mise K, Ueno T, Takaichi K, Matsumoto K, Morita K. Cyst infection in autosomal dominant polycystic kidney disease: penetration of meropenem into infected cysts. BMC Nephrol. 2018;19:272.","journal-title":"BMC Nephrol."},{"key":"1928_CR36","first-page":"73","volume":"67","author":"K Yamaguchi","year":"2014","unstructured":"Yamaguchi K, Ishii Y, Tateda K, Iwata M, Watanabe N, Shinagawa M, Kayaba H, Kimura M, Suwabe A, Kaku M, Abe Y, Kanemitsu K, Taniguchi N, Murakami M, Maesaki S, Kawamura T, Nomura F, Watanabe M, Kanno H, Horiuchi H, Tazawa Y, Kondo S, Misawa S, Takemura H, Nakashima H, Matsuto T, Fujimoto Y, Ishigo S, Gotoh H, Watanabe O, Yagi T, Shimaoka N, Mikamo H, Yamagishi Y, Fujita N, Komori T, Ichiyama S, Kawano S, Nakayama A, Nakamura F, Kohno H, Fukuda S, Kusano N, Nose M, Yokozaki M, Onodera M, Murao K, Negayama K, Nishimiya T, Miyamoto H, Matsunaga A, Yoshimura H, Kohno S, Yanagihara K. Hiramatsu K [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2012]. Japanese J Antibio. 2014;67:73\u2013107.","journal-title":"Japanese J Antibio"},{"key":"1928_CR37","first-page":"163","volume":"41","author":"MJ Hepburn","year":"2003","unstructured":"Hepburn MJ, Pennick GJ, Sutton DA, Crawford GE, Jorgensen JH. Candida krusei renal cyst infection and measurement of amphotericin B levels in cystic fluid in a patient receiving Am Bisome. Med Mycol. 2003;41:163\u20135.","journal-title":"Med Mycol."},{"key":"1928_CR38","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1186\/s12879-019-4444-y","volume":"19","author":"L Onuchic","year":"2019","unstructured":"Onuchic L, Sato VAH, de Menezes Neves PDM, Balbo BEP, Portela-Neto AA, Ferreira FT, Watanabe EH, Watanabe A, de Almeida MCS, de Abreu Testagrossa L, Chocair PR, Onuchic LF. Two cases of fungal cyst infection in ADPKD: is this really a rare complication? BMC Infect Dis. 2019;19:911.","journal-title":"BMC Infect Dis."},{"key":"1928_CR39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/JCM.41.1.479-482.2003","volume":"41","author":"AA Padhye","year":"2003","unstructured":"Padhye AA, Verghese S, Ravichandran P, Balamurugan G, Hall L, Padmaja P, Fernandez MC. Trichosporon loubieri infection in a patient with adult polycystic kidney disease. J Clin Microbiol. 2003;41:479\u201382.","journal-title":"J Clin Microbiol."},{"key":"1928_CR40","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4103\/1319-2442.135175","volume":"25","author":"SP Nagaraju","year":"2014","unstructured":"Nagaraju SP, Gupta A, McCormick BB, Khandelwal A. Emphysematous polycystic infection in a patient on peritoneal dialysis. Saudi J Kidney Dis Transpl. 2014;25:837\u20139.","journal-title":"Saudi J Kidney Dis Transpl."},{"issue":"Suppl 3","key":"1928_CR41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1469-0691.2000.tb02042.x","volume":"6","author":"T Mazzei","year":"2000","unstructured":"Mazzei T, Dentico P. The pharmacokinetics of oral cephalosporins. Clin Microbiol Infect. 2000;6(Suppl 3):53\u20134.","journal-title":"Clin Microbiol Infect."},{"key":"1928_CR42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0924-8579(00)00285-5","volume":"16","author":"A Novelli","year":"2000","unstructured":"Novelli A, Fallani S, Cassetta MI, Conti S. Pharmacokinetics and pharmacodynamics of oral cephalosporins as critical factors in choice of antibiotics. Int J Antimicrob Agents. 2000;16:501\u20135.","journal-title":"Int J Antimicrob Agents."},{"key":"1928_CR43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jiac.2014.04.013","volume":"20","author":"A Morita","year":"2014","unstructured":"Morita A, Kamei S, Minami M, Yoshida K, Kawabata S, Kuroda H, Suzuki Y, Araki N, Iwasaki Y, Kobayashi R, Hayashi N, Hirayama T, Ochiai J, Ueda M, Yamagishi Y, Niwa J, Shindo K, Fukushima Y, Takita T, Sato T, Sato S, Mikamo H, Iwata S. Open-label study to evaluate the pharmacodynamics, clinical efficacy, and safety of meropenem for adult bacterial meningitis in Japan. J Infec Chemotherapy. 2014;20:535\u201340.","journal-title":"J Infec Chemotherapy."},{"key":"1928_CR44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0272-6386(12)81025-0","volume":"16","author":"AB Chapman","year":"1990","unstructured":"Chapman AB, Thickman D, Gabow PA. Percutaneous cyst puncture in the treatment of cyst infection in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1990;16:252\u20135.","journal-title":"Am J Kidney Dis."},{"key":"1928_CR45","unstructured":"Harris PC, Torres VE. Polycystic kidney disease, Autosomal Dominant. In: Adam MP, editor. GeneReviews\u00ae[Internet]. Seattle: University of Washington; 2015."},{"key":"1928_CR46","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1053\/ajkd.2002.31407","volume":"39","author":"Y Ubara","year":"2002","unstructured":"Ubara Y, Tagami T, Sawa N, Katori H, Yokota M, Takemoto F, Inoue S, Kuzuhara K, Hara S, Yamada A. Renal contraction therapy for enlarged polycystic kidneys by transcatheter arterial embolization in hemodialysis patients. Am J Kidney Dis. 2002;39:571\u20139.","journal-title":"Am J Kidney Dis."},{"key":"1928_CR47","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10157-012-0622-6","volume":"16","author":"M Yamanouchi","year":"2012","unstructured":"Yamanouchi M, Ubara Y, Takaichi K. Emphysematous cyst infection in autosomal dominant polycystic kidney disease. Clin Experim Nephrol. 2012;16:505\u20136.","journal-title":"Clin Experim Nephrol."},{"key":"1928_CR48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature18849","volume":"535","author":"AJ Baumler","year":"2016","unstructured":"Baumler AJ, Sperandio V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature. 2016;535:85\u201393.","journal-title":"Nature."},{"key":"1928_CR49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature18847","volume":"535","author":"CA Thaiss","year":"2016","unstructured":"Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature. 2016;535:65\u201374.","journal-title":"Nature."},{"issue":"Suppl 1","key":"1928_CR50","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1038\/mi.2008.52","volume":"1","author":"M Boirivant","year":"2008","unstructured":"Boirivant M, Amendola A, Butera A. Intestinal microflora and immunoregulation. Mucosal Immunol. 2008;1(Suppl 1):S47\u20139.","journal-title":"Mucosal Immunol."},{"key":"1928_CR51","doi-asserted-by":"crossref","first-page":"e91857","DOI":"10.1371\/journal.pone.0091857","volume":"9","author":"Y Kotani","year":"2014","unstructured":"Kotani Y, Kunisawa J, Suzuki Y, Sato I, Saito T, Toba M, Kohda N, Kiyono H. Role of Lactobacillus pentosus Strain b240 and the Toll-like receptor 2 axis in Peyer's patch dendritic cell-mediated immunoglobulin A enhancement. PLoS One. 2014;9:e91857.","journal-title":"PLoS One."},{"key":"1928_CR52","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/587658","volume":"46","author":"P Katona","year":"2008","unstructured":"Katona P, Katona-Apte J. The interaction between nutrition and infection. Clin Infect Dis. 2008;46:1582\u20138.","journal-title":"Clin Infect Dis."},{"key":"1928_CR53","doi-asserted-by":"crossref","first-page":"336S","DOI":"10.1093\/jn\/133.1.336S","volume":"133","author":"GT Keusch","year":"2003","unstructured":"Keusch GT. The history of nutrition: malnutrition, infection and immunity. J Nutr. 2003;133:336S\u201340S.","journal-title":"J Nutr."},{"key":"1928_CR54","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02355122","volume":"2","author":"Y Muraya","year":"1996","unstructured":"Muraya Y, Oozono Y, Kadota JI, Miyazaki M, Hashimoto A, Iida K, Kawakami K, Shirai R, Kaku M, Koga H, Harada T, Kohno S, Hara K. Clinical and Immunological Evaluation of Infection in Patients on Hemodialysis. J Infec Chemotherapy. 1996;2:247\u201353.","journal-title":"J Infec Chemotherapy."}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-020-01928-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-020-01928-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-020-01928-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:06:10Z","timestamp":1626912370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-020-01928-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1928"],"URL":"https:\/\/doi.org\/10.1007\/s10157-020-01928-2","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,22]]},"assertion":[{"value":"10 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}]}}